---
title: "Veracyte to report Q2 results, host conference call"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292237271.md"
description: "Veracyte Inc. announced it will release its second-quarter 2026 financial results on July 30, 2026. The company's management will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results."
datetime: "2026-07-09T20:05:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292237271.md)
  - [en](https://longbridge.com/en/news/292237271.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292237271.md)
generator: "portal-rs"
---

# Veracyte to report Q2 results, host conference call

-   Veracyte schedules release of second-quarter 2026 financial results for July 30, 2026. \* Management to host a conference call, webcast on July 30, 2026 at 4:30 p.m. ET; live link: here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607091605BIZWIRE\_USPR\_\_\_\_\_20260709\_BW945913) on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [VCYT.US](https://longbridge.com/en/quote/VCYT.US.md)

## Related News & Research

- [Veracyte director Jens Holstein disposes of USD 204,747 common shares](https://longbridge.com/en/news/299229413.md)
- [Veracyte director Muna Bhanji disposes of 1,864 common shares worth $80,086.08](https://longbridge.com/en/news/297957715.md)
- [Bank of America Q3 Preview: Stock Down in 2026, Could 5th Straight Double Beat Change Momentum?](https://longbridge.com/en/news/301739892.md)
- [CoreWeave Chief Revenue Officer Jonathan Jones Reports Disposal of $2.94 Million in Common Shares](https://longbridge.com/en/news/301896236.md)
- [Veracyte Decipher Prostate test predicts benefit of adding hormone therapy to radiation in Phase III trial analysis](https://longbridge.com/en/news/300433103.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**